Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity.
AbbVie, Lilly, Sanofi, Merck and J&J are included in this Analyst Blog.
There's no better time than October to invest in high-quality dividend stocks. Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October. Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).